Search - tctmd.com

Displaying 741 - 760 of 2954

Sort: Relevancy | Date

Presentation TCT 2019

Flash Debate: Drug-Coated Balloons Are the Best Treatment for ISR and Avoids Further Stent Layers!

Presenter: Paul Ong

September 27, 2019

Presentation TCT 2019

How to Treat Stent Thrombosis: Case-Based Vignettes of Different Approaches

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Presenter: Sandeep Basavarajaiah

September 27, 2019

Presentation TCT 2019

Very Late Stent Failure: Frequency and Predictive Factors

Presenter: Mahesh Madhavan

September 27, 2019

Presentation TCT 2019

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Presenter: Bruno Scheller

September 27, 2019

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Presenter: Giulio Guagliumi

September 27, 2019

Presentation TCT 2019

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

Presenter: Aloke Finn

September 27, 2019

Presentation TCT 2019

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Presenter: Jeffrey Popma

September 27, 2019

Presentation TCT 2019

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

Presenter: Divaka Perera

September 27, 2019

Presentation TCT 2019

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

Preview From the Upcoming Ischemia Trial

Presenter: David Maron

September 27, 2019

Presentation TCT 2019

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Presenter: Jean Fajadet

September 27, 2019

Presentation TCT 2019

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Presenter: Fazila Malik

September 27, 2019

Presentation TCT 2019

Potential Study Designs to Address the Mortality Safety Signal

Presenter: Laura Mauri

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients in Japan

Presenter: Yasuko Nakamura

September 26, 2019

Presentation TCT 2019

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Presenter: Adrian Magee

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

Ultrathin Orsiro: Where It Can Go

Presenter: Steven Yakubov

September 26, 2019

Advertisement

Flash Debate: Drug-Coated Balloons Are the Best Treatment for ISR and Avoids Further Stent Layers!

How to Treat Stent Thrombosis: Case-Based Vignettes of Different Approaches

Clinical Outcome at 6 Months Between Paclitaxel-Coated Balloon vs. Sirolimus-Coated Balloon in De Novo Coronary Lesions

Very Late Stent Failure: Frequency and Predictive Factors

Absence of Risk of Death After Coronary Paclitaxel-Coated Balloons: Systematic Review and Meta-Analysis of Randomized Trials

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Intravascular Imaging Insights

Root Causes of Thrombosis and Restenosis With Contemporary Metallic DES: Pathologic Insights

PROTECT III First Look: High-Risk PCI Outcomes in 800 Impella-Supported Patients

Elective High-Risk PCI and Hemodynamic Support: Evidence-Based and Experience-Based Recommendations

PCI vs. CABG in Multivessel Disease (With and Without Diabetes): Latest Clinical Trial Data

Preview From the Upcoming Ischemia Trial

Revascularization in Stable CAD: What Do the New 2019 ESC Guidelines Recommend?

Clinical Trial Design in HBR Patients: Should Risk Scores Be Incoporated?

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Potential Study Designs to Address the Mortality Safety Signal

Study Design Considerations for HBR Patients in Japan

Study Design Considerations for HBR Patients and DES Platforms: FDA View

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Ultrathin Orsiro: Where It Can Go

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content